40 participants
Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-12
- Start Date:
- 2026-04-30
- Completion:
- 2028-12-31
Conditions
- Colorectal Cancer
- KRAS G12C Mutant Advanced Solid Tumors
- Fulzerasib
- Cetuximab N01
Interventions
- DRUG
No Results Yet